Last update :
19/11/2024
Antibiotic   Telavancin hydrochloride  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Vibativ Canada, Great Britain, United States of America
References   injection   References : Telavancin hydrochloride  
Type Publication
2006 Journal Gu Z, Wong A, Raquinio E, Nguyen A.
Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags.
Hosp Pharm 2015 ; 50, 7: 609-614.
3254 Journal Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3260 Manufacturer Telavancin (Vibativ®) - Summary of Products characteristics
Astellas Pharma Europe 2011
3327 Journal LaPlante K.L, Woodmansee S, Mermel L.A.
Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
Am J Health-Syst Pharm 2012 ; 69:1405-1409
3835 Journal Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C.
Chemical Stability of Telavancin in Elastomeric Pumps.
Current Ther Res 2015 ; 77: 99-104.
3839 Journal Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T.
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions.
Current Ther Res 2015 ; 77: 105-110.

  Mentions Légales